Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics

被引:78
作者
Balijepalli, S
Kenchappa, RS
Boyd, MR
Ravindranath, V
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bangalore 560029, Karnataka, India
[2] NCI, Frederick Canc Res & Dev Ctr, Dev Therapeut Program, Lab Drug Discovery Res & Dev, Frederick, MD 21702 USA
[3] Natl Brain Res Ctr, New Delhi 110067, India
关键词
antipsychotic; haloperidol; brain; complex I; mitochondria; oxidative stress;
D O I
10.1016/S0197-0186(00)00108-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Usage of 'typical' but not 'atypical' antipsychotic drugs is associated with severe side effects involving extrapyramidal tract (EPT). Single dose of haloperidol caused selective inhibition of complex I in frontal cortex, striatum and midbrain (41 and 26%, respectively) which was abolished by pretreatment of mice with thiol antioxidants, alpha -lipoic acid and glutathione isopropyl ester: and reversed, in vitro, by disulfide reductant, dithiothreitol. Prolonged administration of haloperidol to mice resulted in complex I loss in frontal cortex, hippocampus, striatum and midbrain, while chronic dosing with clozapine affected only hippocampus and frontal cortex. Risperidone caused complex I loss in frontal cortex, hippocampus and striatum but not in midbrain from which extrapyramidal tract emanates. Inhibition of the electron transport chain component, complex I by haloperidol is mediated through oxidation of essential thiol groups to disulfides, in vivo. Further, loss of complex I in extrapyramidal brain regions by anti-psychotics correlated with their known propensity to generate side-effects involving extra-pyramidal tract. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:425 / 435
页数:11
相关论文
共 37 条
[1]   Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation [J].
Balijepalli, S ;
Boyd, MR ;
Ravindranath, V .
NEUROPHARMACOLOGY, 1999, 38 (04) :567-577
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517
[4]  
CASEY DE, 1991, CURR OPIN PSYCHIATR, V4, P86
[5]  
CHUNG AS, 1982, BIOCHEM PHARMACOL, V31, P3093
[6]   DEPRENYL SUPPRESSES THE OXIDANT STRESS ASSOCIATED WITH INCREASED DOPAMINE TURNOVER [J].
COHEN, G ;
SPINA, MB .
ANNALS OF NEUROLOGY, 1989, 26 (05) :689-690
[7]   Energy thresholds in brain mitochondria - Potential involvement in neurodegeneration [J].
Davey, GP ;
Peuchen, S ;
Clark, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12753-12757
[8]  
DUPIUS A, 1991, BIOCHEM J, V277, P11
[9]   VITAMIN-E ATTENUATES THE DEVELOPMENT OF HALOPERIDOL-INDUCED DOPAMINERGIC HYPERSENSITIVITY IN RATS - POSSIBLE IMPLICATIONS FOR TARDIVE-DYSKINESIA [J].
GATTAZ, WF ;
EMRICH, A ;
BEHRENS, S .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 92 (2-3) :197-201
[10]  
GIBSON SL, 1983, CANCER RES, V43, P4191